Filter
337
Filtered Results: 337
Text search:
drogen
Featured
Recommendations
33
New Publications
74
Language
Document type
No document type
154
Studies & Reports
60
Guidelines
43
Brochures
30
Fact sheets
18
Manuals
12
Strategic & Response Plan
7
Training Material
5
Resource Platforms
3
Infographics
3
Dashboards/Maps
1
App
1
Countries / Regions
Germany
137
Eastern Europe
13
Western and Central Europe
6
Russia
6
Global
4
Congo, Democratic Republic of
4
Switzerland
3
Ukraine
3
Senegal
2
Malawi
2
Venezuela
2
Indonesia
2
India
2
Tajikistan
1
Nepal
1
Kenya
1
Serbia
1
Benin
1
Togo
1
China
1
Rwanda
1
Syria
1
Nigeria
1
Burkina Faso
1
Peru
1
Austria
1
Mozambique
1
USA
1
Haiti
1
Asia
1
Saudi Arabia
1
Middle East and North Africa
1
South–East Asia Region
1
Paraguay
1
Belarus
1
South Africa
1
Brazil
1
Egypt
1
Yemen
1
Georgia
1
Ethiopia
1
Angola
1
Chad
1
South Sudan
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
42
Public Health
11
Women & Child Health
10
Clinical Guidelines
9
Key Resources
3
Capacity Building
1
Toolboxes
Refugee
150
Mental Health
76
NCDs
29
Global Health Education
22
COVID-19
14
TB
12
Planetary Health
6
Health Financing Toolbox
6
HIV
5
Conflict
5
Ebola & Marburg
3
Social Ethics
3
Pharmacy
3
Disability
2
Caregiver
2
AMR
2
Rapid Response
1
Specific Hazards
1
Welcome to the Global Information System on Resources for the Prevention and Treatment of Substance Use Disorders. These pages present data collected from WHO Member States in broad categories: governance, policy and financing, service organization and delivery, human resources and national informat...
This guide helps pharmacists to understand their role in the hypertension program. From maintaining hypertensive drug stock, to drug dispensing, to recording and reporting, to awareness generation with patients.
Shown in blue is the estimated annual number of deaths attributed to drug use. Shown in red is theestimated annual number of deaths from drug use disorders. The difference between them is that theyrelate to indirect and direct causes of death, respectively.
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A...
Estimated annual number of deaths from drug use disorders, by type of drug.
Background
The core clinical symptoms of addiction include an enhanced incentive for drug taking (craving), impaired self-control (impulsivity and compulsivity), emotional dysregulation (negative mood) and increased stress reactivity. Symptoms related to impaired self-control involve reduced activi...
Estimated annual number of deaths from drug use disorders per 100,000 people.
The pamphlet "What is Addiction" explains addiction as a chronic, relapsing brain disease characterized by compulsive drug seeking and use, despite harmful consequences. It highlights the dangers of different drug categories, including sedatives, stimulants, and hallucinogens, and their potential he...
The CDC webpage "Types of Insulin" provides an overview of the various insulin types used in diabetes management, categorized by their onset, peak time, and duration of action. It explains terms like onset (how quickly insulin lowers blood sugar), peak time (when insulin is at maximum strength), and...
The IHME webpage discusses alcohol use as a significant global health risk, responsible for over 1.8 million deaths annually. It highlights age-related differences in alcohol's health impacts, with no benefits for individuals aged 15–39 and potential small benefits for those aged 40 and above unde...
The pamphlet "ADHD Medications" provides an overview of medications commonly used to treat ADHD, such as Adderall, Vyvanse, and Ritalin. It explains that these medications do not enhance intelligence and affect individuals differently based on dosage and medical history. Potential dangers of misuse ...
The webpage by the National Institute on Drug Abuse (NIDA) discusses strategies for preventing drug misuse and addiction. It highlights the importance of early intervention, education, and support systems to reduce risk factors and strengthen protective factors. The content emphasizes the role of fa...
The World Health Organization (WHO) launched the SAFER initiative in 2018 to address the global health and societal challenges posed by alcohol-related harm. The initiative outlines five key strategies aimed at reducing alcohol consumption and its associated consequences. These include strengthening...
The World Health Organization's fact sheet on opioid overdose highlights the significant global health issue posed by opioids, which include natural, semi-synthetic, and synthetic compounds used primarily for pain management. Misuse and unsupervised use can lead to dependence and severe health probl...
The pamphlet "Prescription Benzodiazepines" explains the uses, effects, and risks of benzodiazepines, commonly prescribed for insomnia, anxiety, and panic attacks. It describes how these drugs enhance GABA activity to suppress brain activity, leading to short-term effects like drowsiness and anxiety...
The World Health Organization's Eastern Mediterranean Regional Office (WHO EMRO) highlights the significant health and social consequences of harmful alcohol use. Excessive alcohol consumption is linked to over 200 diseases and injuries, including liver cirrhosis, pancreatitis, various cancers, hemo...
The report provides an overview of alcohol consumption, related health harm, and policy responses in 30 European countries (EU Member States, Norway, and Switzerland). It highlights the high levels of alcohol consumption in the WHO European Region, which contribute to a significant disease burden co...
The OECD's "Alcohol Consumption" indicator measures the annual sales of pure alcohol in liters per person aged 15 and older. This metric helps assess long-term trends in alcohol consumption across countries. It's important to note that the methodology for converting alcoholic beverages to pure alcoh...
Cardiovascular diseases (CVD) represent the highest burden of disease globally. Medicines are a critical intervention used to prevent and treat CVD. This review describes access to medication for CVD from a health system perspective and strategies that have been used to promote access, including pro...
Psychoactive drugs are substances that, when taken in or administered into one's system, affect mental processes, e.g. perception, consciousness, cognition or mood and emotions. Psychoactive drugs belong to a broader category of psychoactive substances that include also alcohol and nicotine. “Psy...
